CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20,000 target
Drug / intervention
Mass treatment with oral azithromycin to an entire villagedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00221364
NCT00221364Phase 4Completed
CompareCT.gov

Trachoma Elimination With Repeated Mass Azithromycin Treatments

University of California, San Francisco·interventional·Posted Sep 22, 2005·Updated Jul 15, 2015

In Brief

A Phase 4 clinical trial evaluating Mass treatment with oral azithromycin to an entire village for Trachoma and Chlamydia. Completed, enrolled 20,000 participants across 1 site.

Detailed Summary

The WHO has initiated a program to eliminate blinding trachoma by the year 2020, in large part by mass oral azithromycin distributions. It is not clear how frequently or for how long these treatments are necessary. Here we assess the frequency and duration of treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrachoma, Chlamydia
CountriesEthiopia
Collaborators--

Timeline

Phase 4CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartMar 1, 2003
Primary CompletionApr 1, 2005
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 20.8 years ago

Interventions

Mass treatment with oral azithromycin to an entire villagedrug